Literature DB >> 6329251

Disturbances of cardiac rhythm and conduction in familial amyloidosis with polyneuropathy.

P Eriksson, K Karp, P Bjerle, B O Olofsson.   

Abstract

Sixteen consecutive patients with familial amyloidosis with polyneuropathy of varying duration and severity underwent 24 hour ambulatory electrocardiographic monitoring. A high incidence of sinus node dysfunction, supraventricular and ventricular arrhythmias, and disturbances of atrioventricular conduction was found. Considerably more arrhythmias and disturbances of conduction were detected by long term electrocardiographic monitoring than by conventional 12 lead electrocardiograms. During a follow up period of three to 14 months five patients needed treatment by a pacemaker, three of them because of symptomatic complete heart block, one because of second degree heart block with heart failure, and one because of symptomatic dysfunction of the sinus node. The tachyarrhythmias did not require specific treatment. Long term electrocardiographic monitoring is a useful adjunct in the evaluation of patients with familial amyloidosis with polyneuropathy as it may detect otherwise unrecognised symptomatic disturbances of heart rhythm. The results may be valid also for other forms of amyloidosis involving the heart.

Entities:  

Mesh:

Year:  1984        PMID: 6329251      PMCID: PMC481569          DOI: 10.1136/hrt.51.6.658

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  18 in total

1.  Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden.

Authors:  R Andersson
Journal:  Acta Med Scand Suppl       Date:  1976

2.  A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves.

Authors:  C ANDRADE
Journal:  Brain       Date:  1952-09       Impact factor: 13.501

3.  The conduction system in cardiac amyloidosis. Clinical and pathologic features of 23 patients.

Authors:  R L Ridolfi; B H Bulkley; G M Hutchins
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

4.  Conduction disturbances in 190 patients with familial amyloidotic polyneuropathy (Andrade's type).

Authors:  A Falcão De Freitas; A Barbedo
Journal:  Adv Cardiol       Date:  1978

Review 5.  Atrioventricular and intraventricular conduction. Revised nomenclature and concepts.

Authors:  H H Hecht; C E Kossmann; R W Childers; R Langendorf; M Lev; K M Rosen; R D Pruitt; R C Truex; H N Uhley; T B Watt
Journal:  Am J Cardiol       Date:  1973-02       Impact factor: 2.778

Review 6.  The frequency and prognostic significance of electrocardiographic abnormalities in clinically normal individuals.

Authors:  P A Barrett; C T Peter; H J Swan; B N Singh; W J Mandel
Journal:  Prog Cardiovasc Dis       Date:  1981 Jan-Feb       Impact factor: 8.194

7.  The sinoatrial node in familial amyloidosis with polyneuropathy. A clinico-pathological study of nine cases from northern Sweden.

Authors:  A Eriksson; P Eriksson; B O Olofsson; L E Thornell
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

8.  Definition of terms related to cardiac rhythm.

Authors: 
Journal:  Am Heart J       Date:  1978-06       Impact factor: 4.749

9.  Amyloidosis: review of 236 cases.

Authors:  R A Kyle; E D Bayrd
Journal:  Medicine (Baltimore)       Date:  1975-07       Impact factor: 1.889

10.  Noninvasive cardiovascular findings in familial amyloid polyneuropathy.

Authors:  T Sawayama; T Kurihara; S Araki
Journal:  Br Heart J       Date:  1978-11
View more
  7 in total

Review 1.  Transthyretin Cardiac Amyloidosis.

Authors:  Anit K Mankad; Keyur B Shah
Journal:  Curr Cardiol Rep       Date:  2017-08-24       Impact factor: 2.931

2.  Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy.

Authors:  P Eriksson; C Backman; P Bjerle; A Eriksson; S Holm; B O Olofsson
Journal:  Br Heart J       Date:  1984-09

3.  Recent advances in the treatment of familial amyloid polyneuropathy.

Authors:  David Adams
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

4.  Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis.

Authors:  Thibaud Damy; Daniel P Judge; Arnt V Kristen; Karine Berthet; Huihua Li; Janske Aarts
Journal:  J Cardiovasc Transl Res       Date:  2015-03-06       Impact factor: 4.132

5.  Domino living donor liver transplantation of familial amyloid polyneuropathy patient - A case report.

Authors:  Sungrok Cha; Jiwon Kim; Soo Joo Choi; Gaab Soo Kim
Journal:  Anesth Pain Med (Seoul)       Date:  2020-10-14

Review 6.  Deciphering hypertrophic cardiomyopathy with electrocardiography.

Authors:  Thomas Gossios; Konstantinos Savvatis; Thomas Zegkos; Dimitrios Ntelios; Pavlos Rouskas; Despoina Parcharidou; Haralambos Karvounis; Georgios K Efthimiadis
Journal:  Heart Fail Rev       Date:  2021-07-21       Impact factor: 4.654

7.  (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis.

Authors:  Björn Pilebro; Ole B Suhr; Ulf Näslund; Per Westermark; Per Lindqvist; Torbjörn Sundström
Journal:  Ups J Med Sci       Date:  2016-02-05       Impact factor: 2.384

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.